Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mahoney

Showing results (131-140 of 164) with videos related to

Pageof 17
Sort By:
The Journal of Physical Chemistry. B|March 13, 2015
Tailoring cyanine dark states for improved optically modulated fluorescence recoveryDaniel P Mahoney, Eric A Owens, Chaoyang Fan, et al.
Lancet (London, England)|September 24, 1983
Vegetarian diet and blood pressureI L Rouse, L J Beilin, D P Mahoney, et al.
Birth Defects Original Article Series|March 1, 1973
Renal transplantation in childhood cystinosis: effects of the metabolic disease and renal allografts on each otherC P Mahoney, G E Striker, G H Fetterman, et al.
Journal of Pharmaceutical Sciences|June 28, 2021
Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody SolutionsYuhong Zeng, Timothy Tran, Philip Wuthrich, et al.
Journal of Veterinary Internal Medicine|October 18, 2007
Feline acromegaly: an underdiagnosed endocrinopathy?S J M Niessen, G Petrie, F Gaudiano, et al.
Journal of Medicinal Chemistry|December 22, 2025
1-Hydroxy-1,8-napthyridinone (DHN) Analogs Potently Inhibit Monkeypox Virus Resolvase (Mpr)Samuel Offei, Jacob P Mahoney, Ziyue Wang, et al.
Bone|May 4, 2004
Efficacy and safety of ibandronate given by intravenous injection once every 3 monthsS Adami, D Felsenberg, C Christiansen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 17, 2004
Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE studyR R Recker, R S Weinstein, C H Chesnut, et al.
Annals of the Rheumatic Diseases|September 16, 2003
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal womenJ A Stakkestad, L I Benevolenskaya, J J Stepan, et al.
RSC Medicinal Chemistry|June 24, 2026
3-Hydroxypyrimidine-2,4-dione derivatives as monkeypox virus resolvase (Mpr) inhibitorsMuhammad Syafiq Bin Shahari, Jacob P Mahoney, Ziyue Wang, et al.
Pageof 17

Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
The Journal of Physical Chemistry. B|March 13, 2015
Tailoring cyanine dark states for improved optically modulated fluorescence recoveryDaniel P Mahoney, Eric A Owens, Chaoyang Fan, et al.
Lancet (London, England)|September 24, 1983
Vegetarian diet and blood pressureI L Rouse, L J Beilin, D P Mahoney, et al.
Birth Defects Original Article Series|March 1, 1973
Renal transplantation in childhood cystinosis: effects of the metabolic disease and renal allografts on each otherC P Mahoney, G E Striker, G H Fetterman, et al.
Journal of Pharmaceutical Sciences|June 28, 2021
Caffeine as a Viscosity Reducer for Highly Concentrated Monoclonal Antibody SolutionsYuhong Zeng, Timothy Tran, Philip Wuthrich, et al.
Journal of Veterinary Internal Medicine|October 18, 2007
Feline acromegaly: an underdiagnosed endocrinopathy?S J M Niessen, G Petrie, F Gaudiano, et al.
Journal of Medicinal Chemistry|December 22, 2025
1-Hydroxy-1,8-napthyridinone (DHN) Analogs Potently Inhibit Monkeypox Virus Resolvase (Mpr)Samuel Offei, Jacob P Mahoney, Ziyue Wang, et al.
Bone|May 4, 2004
Efficacy and safety of ibandronate given by intravenous injection once every 3 monthsS Adami, D Felsenberg, C Christiansen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 17, 2004
Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE studyR R Recker, R S Weinstein, C H Chesnut, et al.
Annals of the Rheumatic Diseases|September 16, 2003
Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal womenJ A Stakkestad, L I Benevolenskaya, J J Stepan, et al.
RSC Medicinal Chemistry|June 24, 2026
3-Hydroxypyrimidine-2,4-dione derivatives as monkeypox virus resolvase (Mpr) inhibitorsMuhammad Syafiq Bin Shahari, Jacob P Mahoney, Ziyue Wang, et al.
Pageof 17